Dr Les Russell
Les has been the CEO of OrganOx since the company was formed in April 2008. He handed over this role to Craig Marshall in January 2017, and has taken up the position of company Chairman. Les holds first class honours and PhD degrees in Chemistry from the University of London and has more than 25 years experience in the medical devices industry.
Prior to joining OrganOx, Les was Managing Director of Chromogenex plc, an AIM listed company developing and manufacturing light devices for non-ablative surgical and cosmetic use. In his 2 years as Managing Director, sales were increased from £2.4m to £4.5m and a loss of £150K reversed into a profit of £376K.
Until 2000, Les was Director of Marketing and Business Strategy for the Biotech Division of Baxter Export Corporation with responsibility for a product portfolio of $60m spanning medical devices and biopharmaceuticals.
Earlier in his career, he worked with Ilford Limited, Ciba-Corning Diagnostics and Cambridge Life Sciences plc. At Cambridge Life Sciences he had the role of Business Development Director with board responsibility for R&D and business development activities where he was instrumental in the sale of the company to Medirace (Medeva) and then to Byk-Gulden and also in the acquisition of Walker Laboratories.